Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of
substantial morbidity and mortality in the future. The complexity and uncertainty related to …

We are entering an important new chapter in the story of hepatitis C virus (HCV) infection.
There are clear challenges and opportunities. On the one hand, new HCV infections are still …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Objective. Illicit drug use is identified in Healthy People 2010 as a leading health indicator
because it is associated with multiple deleterious health outcomes, such as sexually …

ContextHepatitis C virus (HCV) infection may resolve (viral clearance), persist without
complications, or cause end-stage liver disease (ESLD). The frequency and determinants of …

Abstract The recent National Health and Nutrition Examination Survey (NHANES) sampled
only the civilian, non‐institutionalized population of USA and may have underestimated the …

Highly active antiretroviral therapy has decreased human immunodeficiency virus (HIV)-
associated mortality; other comorbidities, such as chronic liver disease, are assuming …

Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at
risk for other infectious pathogens, including hepatitis B virus (HBV) or hepatitis C virus …

Designing studies to examine hepatitis C virus (HCV) transmission via the shared use of
drug injection paraphernalia other than syringes is difficult because of saturation levels of …

We characterized hepatitis C virus (HCV) treatment knowledge, experience and barriers in a
cohort of community-based injection drug users (IDUs) in Baltimore, MD. In 2005, a …